Milutinović S, Breyer D, Janković M, Stefović A, Molnar V, Mrzljak V, Rocić B
Proc Eur Dial Transplant Assoc. 1983;19:763-8.
Insulin binding to erythrocytes obtained from uraemic patients was determined using a radioreceptor assay. The binding was reduced by 50 per cent in 20 non-diabetic uraemic patients in comparison with 20 controls (4.7 +/- 1.79 vs 9.37 +/- 1.30 (mean +/- SD) p less than 0.01). During the course of haemodialysis insulin binding steadily increased in a time dependent manner in proportion to the efficiency of haemodialysis as assessed by relative decrease in plasma urea, uric acid or creatinine. Incubation of healthy donors' erythrocytes with uraemic plasma resulted in a dose dependent inhibition of insulin binding with a maximum of 40 per cent. These data indicate the presence of dialysable inhibitors of insulin binding in uraemic plasma.
采用放射受体分析法测定尿毒症患者红细胞对胰岛素的结合情况。与20名对照者相比,20名非糖尿病尿毒症患者的胰岛素结合率降低了50%(分别为4.7±1.79和9.37±1.30(平均值±标准差),p<0.01)。在血液透析过程中,胰岛素结合率随时间稳步增加,与通过血浆尿素、尿酸或肌酐相对降低评估的血液透析效率成比例。用尿毒症血浆孵育健康供体的红细胞会导致胰岛素结合呈剂量依赖性抑制,最大抑制率为40%。这些数据表明尿毒症血浆中存在可透析的胰岛素结合抑制剂。